Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of kinase inhibitors. Shows potential in medicinal chemistry for targeting neurological disorders, including Alzheimer's disease, dementia, and certain psychiatric conditions, due to its structural affinity with nicotinic acetylcholine receptor (nAChR) modulators. Also employed in the design of novel ligands for central nervous system targets, leveraging its ability to cross the blood-brain barrier. Investigated for use in PET imaging probes because of its favorable binding properties and metabolic stability. Additionally, utilized as a reference compound or intermediate in synthesizing derivatives for laboratory bioactivity screening, with potential to enhance cognition and learning functions.